NASDAQ: IMMX
IMMIX Biopharma Inc Stock Ownership - Who owns IMMIX Biopharma?

Insider buying vs selling

Have IMMIX Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Gabriel S. MorrisCFO2025-12-10770$6.58
$5.07kBuy
Ilya M. RachmanCEO and Chairman2025-12-10746$6.67
$4.98kBuy
Gabriel S. MorrisCFO2025-12-08156,000$0.80
$124.80kBuy
Ilya M. RachmanCEO and Chairman2025-09-172,500$2.02
$5.05kBuy
Gabriel S. MorrisCFO2025-09-162,600$1.97
$5.12kBuy

1 of 1

IMMX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IMMX insiders and whales buy or sell their stock.

IMMX Shareholders

What type of owners hold IMMIX Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Janus Henderson Group PLC8.83%4,802,002$41.87MInstitution
Saturn V Capital Management LP6.79%3,693,585$32.21MInstitution
Yekaterina Chudnovsky5.97%3,247,326$28.32MInsider
Eventide Asset Management LLC4.68%2,549,019$22.23MInstitution
Vanguard Capital Management LLC3.29%1,787,994$15.59MInstitution
Millennium Management LLC3.22%1,750,200$15.26MInstitution
Marshall Wace LLP3.02%1,641,552$14.31MInstitution
Logos Global Management LP2.25%1,225,000$10.68MInstitution
Ilya M. Rachman2.10%1,141,683$9.96MInsider
Carey Ng1.93%1,051,471$9.17MInsider

1 of 3

IMMX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IMMX49.76%17.93%Net Buying
PRTA52.31%47.69%Net BuyingNet Buying
VALN2.25%0.00%
RZLT44.44%55.56%Net BuyingNet Buying
CABA51.93%2.67%Net Buying

IMMIX Biopharma Stock Ownership FAQ

Who owns IMMIX Biopharma?

IMMIX Biopharma (NASDAQ: IMMX) is owned by 49.76% institutional shareholders, 17.93% IMMIX Biopharma insiders, and 32.30% retail investors. Yekaterina Chudnovsky is the largest individual IMMIX Biopharma shareholder, owning 3.25M shares representing 5.97% of the company. Yekaterina Chudnovsky's IMMIX Biopharma shares are currently valued at $28.32M.

If you're new to stock investing, here's how to buy IMMIX Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.